Literature DB >> 32957805

Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease.

George Hindy1, Krishna G Aragam1, Kenney Ng1, Mark Chaffin1, Luca A Lotta1, Aris Baras1, Isabel Drake1, Marju Orho-Melander1, Olle Melander1, Sekar Kathiresan1, Amit V Khera1.   

Abstract

OBJECTIVE: To determine the relationship of a genome-wide polygenic score for coronary artery disease (GPSCAD) with lifetime trajectories of CAD risk, directly compare its predictive capacity to traditional risk factors, and assess its interplay with the Pooled Cohort Equations (PCE) clinical risk estimator. Approach and
Results: We studied GPSCAD in 28 556 middle-aged participants of the Malmö Diet and Cancer Study, of whom 4122 (14.4%) developed CAD over a median follow-up of 21.3 years. A pronounced gradient in lifetime risk of CAD was observed-16% for those in the lowest GPSCAD decile to 48% in the highest. We evaluated the discriminative capacity of the GPSCAD-as assessed by change in the C-statistic from a baseline model including age and sex-among 5685 individuals with PCE risk estimates available. The increment for the GPSCAD (+0.045, P<0.001) was higher than for any of 11 traditional risk factors (range +0.007 to +0.032). Minimal correlation was observed between GPSCAD and 10-year risk defined by the PCE (r=0.03), and addition of GPSCAD improved the C-statistic of the PCE model by 0.026. A significant gradient in lifetime risk was observed for the GPSCAD, even among individuals within a given PCE clinical risk stratum. We replicated key findings-noting strikingly consistent results-in 325 003 participants of the UK Biobank.
CONCLUSIONS: GPSCAD-a risk estimator available from birth-stratifies individuals into varying trajectories of clinical risk for CAD. Implementation of GPSCAD may enable identification of high-risk individuals early in life, decades in advance of manifest risk factors or disease.

Entities:  

Keywords:  coronary artery disease; disease; genome; risk factors; statistics

Mesh:

Year:  2020        PMID: 32957805      PMCID: PMC7577949          DOI: 10.1161/ATVBAHA.120.314856

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk.

Authors:  David M Evans; Peter M Visscher; Naomi R Wray
Journal:  Hum Mol Genet       Date:  2009-06-24       Impact factor: 6.150

2.  Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.

Authors:  Amy Damask; P Gabriel Steg; Gregory G Schwartz; Michael Szarek; Emil Hagström; Lina Badimon; M John Chapman; Catherine Boileau; Sotirios Tsimikas; Henry N Ginsberg; Poulabi Banerjee; Garen Manvelian; Robert Pordy; Sibylle Hess; John D Overton; Luca A Lotta; George D Yancopoulos; Goncalo R Abecasis; Aris Baras; Charles Paulding
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

3.  Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.

Authors:  Nicholas A Marston; Frederick K Kamanu; Francesco Nordio; Yared Gurmu; Carolina Roselli; Peter S Sever; Terje R Pedersen; Anthony C Keech; Huei Wang; Armando Lira Pineda; Robert P Giugliano; Steven A Lubitz; Patrick T Ellinor; Marc S Sabatine; Christian T Ruff
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

4.  Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction.

Authors:  Amit V Khera; Mark Chaffin; Seyedeh M Zekavat; Ryan L Collins; Carolina Roselli; Pradeep Natarajan; Judith H Lichtman; Gail D'Onofrio; Jennifer Mattera; Rachel Dreyer; John A Spertus; Kent D Taylor; Bruce M Psaty; Stephen S Rich; Wendy Post; Namrata Gupta; Stacey Gabriel; Eric Lander; Yii-Der Ida Chen; Michael E Talkowski; Jerome I Rotter; Harlan M Krumholz; Sekar Kathiresan
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

5.  The Malmo Diet and Cancer Study. Design and feasibility.

Authors:  G Berglund; S Elmstähl; L Janzon; S A Larsson
Journal:  J Intern Med       Date:  1993-01       Impact factor: 8.989

6.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Authors:  J L Mega; N O Stitziel; S Kathiresan; M S Sabatine; J G Smith; D I Chasman; M Caulfield; J J Devlin; F Nordio; C Hyde; C P Cannon; F Sacks; N Poulter; P Sever; P M Ridker; E Braunwald; O Melander
Journal:  Lancet       Date:  2015-03-04       Impact factor: 79.321

7.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

8.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  A reference panel of 64,976 haplotypes for genotype imputation.

Authors:  Shane McCarthy; Sayantan Das; Warren Kretzschmar; Olivier Delaneau; Andrew R Wood; Alexander Teumer; Hyun Min Kang; Christian Fuchsberger; Petr Danecek; Kevin Sharp; Yang Luo; Carlo Sidore; Alan Kwong; Nicholas Timpson; Seppo Koskinen; Scott Vrieze; Laura J Scott; He Zhang; Anubha Mahajan; Jan Veldink; Ulrike Peters; Carlos Pato; Cornelia M van Duijn; Christopher E Gillies; Ilaria Gandin; Massimo Mezzavilla; Arthur Gilly; Massimiliano Cocca; Michela Traglia; Andrea Angius; Jeffrey C Barrett; Dorrett Boomsma; Kari Branham; Gerome Breen; Chad M Brummett; Fabio Busonero; Harry Campbell; Andrew Chan; Sai Chen; Emily Chew; Francis S Collins; Laura J Corbin; George Davey Smith; George Dedoussis; Marcus Dorr; Aliki-Eleni Farmaki; Luigi Ferrucci; Lukas Forer; Ross M Fraser; Stacey Gabriel; Shawn Levy; Leif Groop; Tabitha Harrison; Andrew Hattersley; Oddgeir L Holmen; Kristian Hveem; Matthias Kretzler; James C Lee; Matt McGue; Thomas Meitinger; David Melzer; Josine L Min; Karen L Mohlke; John B Vincent; Matthias Nauck; Deborah Nickerson; Aarno Palotie; Michele Pato; Nicola Pirastu; Melvin McInnis; J Brent Richards; Cinzia Sala; Veikko Salomaa; David Schlessinger; Sebastian Schoenherr; P Eline Slagboom; Kerrin Small; Timothy Spector; Dwight Stambolian; Marcus Tuke; Jaakko Tuomilehto; Leonard H Van den Berg; Wouter Van Rheenen; Uwe Volker; Cisca Wijmenga; Daniela Toniolo; Eleftheria Zeggini; Paolo Gasparini; Matthew G Sampson; James F Wilson; Timothy Frayling; Paul I W de Bakker; Morris A Swertz; Steven McCarroll; Charles Kooperberg; Annelot Dekker; David Altshuler; Cristen Willer; William Iacono; Samuli Ripatti; Nicole Soranzo; Klaudia Walter; Anand Swaroop; Francesco Cucca; Carl A Anderson; Richard M Myers; Michael Boehnke; Mark I McCarthy; Richard Durbin
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

View more
  19 in total

Review 1.  Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases.

Authors:  Gad Abraham; Loes Rutten-Jacobs; Michael Inouye
Journal:  Stroke       Date:  2021-08-17       Impact factor: 7.914

2.  Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults.

Authors:  Quinn S Wells; Minoo Bagheri; Aaron W Aday; Deepak K Gupta; Christian M Shaffer; Wei-Qi Wei; Nataraja Sarna Vaitinadin; Sadiya S Khan; Philip Greenland; Thomas J Wang; C Michael Stein; Dan M Roden; Jonathan D Mosley
Journal:  Circ Genom Precis Med       Date:  2021-08-31

Review 3.  Atherosclerosis: Recent developments.

Authors:  Johan L M Björkegren; Aldons J Lusis
Journal:  Cell       Date:  2022-05-02       Impact factor: 66.850

4.  Measured Blood Pressure, Genetically Predicted Blood Pressure, and Cardiovascular Disease Risk in the UK Biobank.

Authors:  So Mi Jemma Cho; Satoshi Koyama; Yunfeng Ruan; Kim Lannery; Megan Wong; Ezimamaka Ajufo; Hokyou Lee; Amit V Khera; Michael C Honigberg; Pradeep Natarajan
Journal:  JAMA Cardiol       Date:  2022-09-28       Impact factor: 30.154

5.  Genome-wide polygenic score to predict chronic kidney disease across ancestries.

Authors:  Atlas Khan; Michael C Turchin; Amit Patki; Vinodh Srinivasasainagendra; Ning Shang; Rajiv Nadukuru; Alana C Jones; Edyta Malolepsza; Ozan Dikilitas; Iftikhar J Kullo; Daniel J Schaid; Elizabeth Karlson; Tian Ge; James B Meigs; Jordan W Smoller; Christoph Lange; David R Crosslin; Gail P Jarvik; Pavan K Bhatraju; Jacklyn N Hellwege; Paulette Chandler; Laura Rasmussen Torvik; Alex Fedotov; Cong Liu; Christopher Kachulis; Niall Lennon; Noura S Abul-Husn; Judy H Cho; Iuliana Ionita-Laza; Ali G Gharavi; Wendy K Chung; George Hripcsak; Chunhua Weng; Girish Nadkarni; Marguerite R Irvin; Hemant K Tiwari; Eimear E Kenny; Nita A Limdi; Krzysztof Kiryluk
Journal:  Nat Med       Date:  2022-06-16       Impact factor: 87.241

6.  Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.

Authors:  Kiran J Biddinger; Sean J Jurgens; Dimitri Maamari; Liam Gaziano; Seung Hoan Choi; Valerie N Morrill; Jennifer L Halford; Amit V Khera; Steven A Lubitz; Patrick T Ellinor; Krishna G Aragam
Journal:  JAMA Cardiol       Date:  2022-07-01       Impact factor: 30.154

Review 7.  Clinical utility of polygenic risk scores for coronary artery disease.

Authors:  Derek Klarin; Pradeep Natarajan
Journal:  Nat Rev Cardiol       Date:  2021-11-22       Impact factor: 49.421

8.  Cross-ancestry genome-wide association studies identified heterogeneous loci associated with differences of allele frequency and regulome tagging between participants of European descent and other ancestry groups from the UK Biobank.

Authors:  Antonella De Lillo; Salvatore D'Antona; Gita A Pathak; Frank R Wendt; Flavio De Angelis; Maria Fuciarelli; Renato Polimanti
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

9.  Lipoprotein(a).

Authors:  Florian Kronenberg
Journal:  Handb Exp Pharmacol       Date:  2022

Review 10.  Monogenic and Polygenic Models of Coronary Artery Disease.

Authors:  Evan D Muse; Shang-Fu Chen; Ali Torkamani
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 3.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.